Want to see MRKR full AI Analyst Report?
Marker Therapeutics (MRKR) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Mt-401-Ots | Mds, Acute Myeloid Leukemia, In Relapse | Phase I | Recruiting | Safety of MT-401-OTS in Patients With Relapsed AML or MDS | Aug 07, 2024 | ― |
| Mt-601 | Non Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Refractory, Non-Hodgkin Lymphoma, Relapsed, Hodgkin Lymphoma, Adult, Hodgkin's Lymphoma, Relapsed, Adult | Phase I | Recruiting | Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma | Mar 14, 2023 | ― |
| Mt-401 | Acute Myeloid Leukemia, Stem Cell Transplantation | Phase II | Completed | Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant | Jul 30, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Mt-401-Ots | Phase I | Mds, Acute Myeloid Leukemia, In Relapse | Recruiting | Safety of MT-401-OTS in Patients With Relapsed AML or MDS | Aug 07, 2024 | ― |
| Mt-601 | Phase I | Non Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Refractory, Non-Hodgkin Lymphoma, Relapsed, Hodgkin Lymphoma, Adult, Hodgkin's Lymphoma, Relapsed, Adult | Recruiting | Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma | Mar 14, 2023 | ― |
| Mt-401 | Phase II | Acute Myeloid Leukemia, Stem Cell Transplantation | Completed | Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant | Jul 30, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Marker Therapeutics (MRKR) have in its pipeline
Marker Therapeutics MRKR is currently developing the following drugs: Mt-401-Ots, Mt-601, Mt-401. These drug candidates are in various stages of clinical development as the company works toward FDA approval.